Article

Ocular surface unfriendly to pathogenic bacteria

Whether or not the ocular surface hosts a live microbiome has been an unresolved question, but findings of a study presented at ARVO 2016 provide further insight on this issue.

Seattle-Whether or not the ocular surface hosts a live microbiome has been an unresolved question, but findings of a study presented at ARVO 2016 provide further insight on this issue.

Presented by Suzanne M. Fleiszig, OD, PhD, and colleagues, the research was conducted in a mouse model and evaluated whether stable bacterial colonization of the ocular surface could be established after deliberate inoculation.

Using a novel method to detect live bacteria, the results indicated that the ocular surface does not host a stable, metabolically active microbiome, noted Dr. Fleiszig, professor of optometry and vision science, Infectious Diseases and Immunity, and Microbiology, Berkeley Optometry, University of California.

Related: What physicians need to know about bacterial resistance

The investigators acknowledged, however, that the study does not rule out the possibility that non-metabolically active bacteria were present on the ocular surface.

In designing their experiment, the researchers noted that findings from previous studies using high-throughput sequencing of the microbial 16s ribosomal gene indicated an abundance of microbes resides on the ocular surface.

More from ARVO: Anti-VEGF shows benefits for CNV with rare diseases

However, that particular analytical method does not distinguish between living and non-viable organisms because it is based on the detection of bacterial nucleic acid.

To overcome that limitation, the investigators used alkyne functionalized D-alanine as a novel marker to identify live microbes because it incorporates into the cell wall of only metabolically active bacteria.

SPONSORED: Join us for dinner and diabetes management tips! Click here if you’re attending ASCRS!

After the performance of this novel labelling technique was confirmed, animal eyes were inoculated with bacteria, including Pseudomonas aeruginosa, Staphylococcus aureus, and a gram-positive commensal organism isolated from the mouse dermis.

Then, groups of animals were sacrificed after 24 or 72 hours for analyses to detect metabolically active bacteria in tear fluid, cornea, and conjunctiva.

Whether inoculated with a high or low bacterial load (~108 or ~104 CFU, respectively), the ocular surface was found to be an inhospitable environment for supporting bacterial colonization, either by the pathogenic organisms or the commensal bacterium.

In eyes assessed at 24 hours after inoculation, clearance rates were >99.99% when the inoculum contained ~108 CFU and >99.75% with the smaller inoculum.

Related: Photoactivation holds promise for keratitis treatment

The results were similar when the analyses were conducted 3 days post-inoculation, and metabolically active bacteria were sparsely found on the cornea (mean 0.50 bacteria/image), they reported.

Investigators from Touro University, Vallejo, CA, and Stanford University, Stanford, CA, collaborated in the project.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.